Robert W Platt

Robert W Platt

McGill University

H-index: 103

North America-Canada

About Robert W Platt

Robert W Platt, With an exceptional h-index of 103 and a recent h-index of 53 (since 2020), a distinguished researcher at McGill University, specializes in the field of Biostatistics, Epidemiology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Evaluating hybrid controls methodology in early‐phase oncology trials: A simulation study based on the MORPHEUS‐UC trial

Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort study

The Complex Estimand of Clone-Censor-Weighting When Studying Treatment Initiation Windows

Variable Selection When Estimating Effects in External Target Populations

What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, Canada

Severe maternal morbidity and mental health hospitalizations or emergency department visits

Impact of COVID-19 pandemic on dispensing of cardiovascular drugs in Norway: An interrupted time series study

Glucagon like peptide‐1 receptor agonists and the risk of skin cancer among patients with type 2 diabetes: Population‐based cohort study

Robert W Platt Information

University

Position

___

Citations(all)

41850

Citations(since 2020)

14965

Cited By

32466

hIndex(all)

103

hIndex(since 2020)

53

i10Index(all)

370

i10Index(since 2020)

290

Email

University Profile Page

Google Scholar

Robert W Platt Skills & Research Interests

Biostatistics

Epidemiology

Top articles of Robert W Platt

Evaluating hybrid controls methodology in early‐phase oncology trials: A simulation study based on the MORPHEUS‐UC trial

Pharmaceutical Statistics

2024/1

Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort study

Circulation: Cardiovascular Quality and Outcomes

2020/3

The Complex Estimand of Clone-Censor-Weighting When Studying Treatment Initiation Windows

arXiv preprint arXiv:2404.15073

2024/4/23

Yi Li
Yi Li

H-Index: 3

Robert W Platt
Robert W Platt

H-Index: 53

Variable Selection When Estimating Effects in External Target Populations

American Journal of Epidemiology

2024/4/15

Robert W Platt
Robert W Platt

H-Index: 53

What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, Canada

BMJ open

2024/4/1

Severe maternal morbidity and mental health hospitalizations or emergency department visits

JAMA network open

2024/4/1

Impact of COVID-19 pandemic on dispensing of cardiovascular drugs in Norway: An interrupted time series study

American Journal of Preventive Medicine

2024/4/1

Glucagon like peptide‐1 receptor agonists and the risk of skin cancer among patients with type 2 diabetes: Population‐based cohort study

Diabetic Medicine

2024/4

Robert W Platt
Robert W Platt

H-Index: 53

Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major Bleeding

2023/1

Soham Rej
Soham Rej

H-Index: 18

Robert W Platt
Robert W Platt

H-Index: 53

Comparative Analysis of Instrumental Variables on the Assignment of Buprenorphine/Naloxone or Methadone for the Treatment of Opioid Use Disorder

Epidemiology

2024/3/1

Standardizing to Specific Target Populations in Distributed Networks and Multi-Site Pharmacoepidemiologic Studies

American Journal of Epidemiology

2024/2/27

Robert W Platt
Robert W Platt

H-Index: 53

Prescribing trends of proton pump inhibitors and histamine blockers among children in the United Kingdom (1998–2019): A population‐based assessment

Pharmacoepidemiology and Drug Safety

2024/2

Robert W Platt
Robert W Platt

H-Index: 53

Penalized G-estimation for effect modifier selection in the structural nested mean models for repeated outcomes

arXiv preprint arXiv:2402.00154

2024/1/31

The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in Pharmacovigilance

Clinical Therapeutics

2024/1/16

Robert W Platt
Robert W Platt

H-Index: 53

Type of infertility and prevalence of congenital malformations

Paediatric and Perinatal Epidemiology

2024/1

First-line opioid agonist treatment as prevention against assisting others in initiating injection drug use: A longitudinal cohort study of people who inject drugs in Vancouver …

Drug and Alcohol Dependence Reports

2023/6/1

Comparative effectiveness of urine drug screening strategies alongside opioid agonist treatment in British Columbia, Canada: a population-based observational study protocol

BMJ open

2023/5/1

Emulating a Target Trial in Perinatal Pharmacoepidemiology: Challenges and Methodological Approaches

2023/12

Robert W Platt
Robert W Platt

H-Index: 53

Prevention of COVID-19 with oral vitamin D supplemental therapy in essential healthcare teams (PROTECT): protocol for a multicentre, triple-blind, randomised, placebo …

BMJ open

2023/5/1

See List of Professors in Robert W Platt University(McGill University)

Co-Authors

academic-engine